Login to Your Account

Inhibitex Files For IPO; Veronate Slated To Start Phase III In 2004

By Karen Pihl-Carey

Friday, March 5, 2004
Inhibitex Inc. joined the ranks of private biotech companies looking to take advantage of a more receptive market with an initial public offering filing aimed at raising $86.25 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription